## SHW: The Sherwin-Williams Company - XLB: Basic Materials

### Executive Summary

No thesis match: MRS_20 -3.4% below STRENGTH zone (4.0-10.0%); PEG 3.14 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-3.5% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($320.09)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. CFO Mistysyn Acquires 223 Of Sherwin-Williams Co [SHW]**
- Source: TradingView | 20251203T235324 | Neutral | Relevance: 100%
- Sherwin-Williams Co's CFO, Allen J. Mistysyn, acquired 223 shares of the company's stock through an exercise and surrender transaction on December 1, 2025. This transaction involved the exercise of 802 shares and the surrender of 579 shares, resulting in ending holdings of 73,923 shares. The Washington Service provides further details on insider trading analysis.

**2. Sherwin-Williams (SHW) CFO exercises options, reports updated direct and indirect holdings**
- Source: Stock Titan | 20251203T182000 | Neutral | Relevance: 100%
- Sherwin-Williams' (SHW) SVP of Finance & CFO, Allen J. Mistysyn, exercised employee stock options for 338 shares at $295.83 and 464 shares at $215.08 on December 1, 2025. The filing also detailed dispositions of shares to cover taxes and updated direct ownership to 13,273â€“13,562 shares, including restricted stock units, along with indirect holdings through a 401(k) plan, a trust, and a spouse. After these transactions, the CFO retains 15,662 and 14,336 remaining stock options from grants made in October 2021 and October 2022, respectively.

**3. The Sherwin-Williams Company $SHW Shares Purchased by Shelton Capital Management**
- Source: MarketBeat | 20251203T125247 | Somewhat-Bullish | Relevance: 100%
- Shelton Capital Management significantly increased its stake in The Sherwin-Williams Company (NYSE:SHW) during the second quarter of 2025, now owning 5,468 shares valued at $1.877 million. This move coincides with Sherwin-Williams exceeding analyst expectations in its recent earnings report and setting optimistic FY2025 guidance. The company maintains a "Moderate Buy" consensus rating from analysts, with various institutional investors also adjusting their positions in SHW.

**4. Granite Investment Partners LLC Has $18.52 Million Stake in The Sherwin-Williams Company $SHW**
- Source: MarketBeat | 20251203T101604 | Somewhat-Bullish | Relevance: 100%
- Granite Investment Partners LLC increased its stake in The Sherwin-Williams Company by 27.3% to 53,948 shares, valued at $18.52 million, in the second quarter. Sherwin-Williams reported strong Q2 earnings, beating revenue and EPS expectations, and issued optimistic FY2025 guidance. The company maintains a "Moderate Buy" consensus rating from analysts with an average price target of $390.87.

**5. 1832 Asset Management L.P. Sells 164,830 Shares of The Sherwin-Williams Company $SHW**
- Source: MarketBeat | 20251203T081259 | Somewhat-Bullish | Relevance: 100%
- 1832 Asset Management L.P. reduced its stake in The Sherwin-Williams Company (NYSE:SHW) by 17.4% in the second quarter, selling 164,830 shares and now owning 784,091 shares valued at $269.23 million. Other institutional investors also made changes to their positions. The article also covers analyst ratings, stock performance data, and recent earnings announcements for Sherwin-Williams.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 16 ($0.21M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 36.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 5 |

**Top Holders:**
- Vanguard Group Inc: 9.1% (+1.4%)
- Blackrock Inc.: 7.1% (-0.7%)
- State Street Corpora: 6.2% (-0.9%)
- Price (T.Rowe) Assoc: 3.6% (-1.7%)
- Morgan Stanley: 2.9% (+1.8%)

### Key Risks

1. Valuation stretched: PEG 3.1x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 3.14 signals overvaluation risk, limited margin of safety. Forward P/E 26.5x stretched relative to 11% growth. Quality metrics strong (ROE 60%). Balance sheet: $1.1B free cash flow. Institutional flow bullish (4 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $81.1B |
| Beta | 1.24 |
| 52W Range | $308.84 - $379.65 |
| Short Interest | 1.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.14 |
| Forward P/E | 26.5 |
| Current P/E | 29.3 |
| YoY Growth | 10.5% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 0.1% to -3.4% (-3.5% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 7.4pp (needs >4.0% for momentum thesis). Below SMA200 (0.96x), long-term trend not supportive. RSI neutral at 44. OFD pattern: -MTN (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -3.39% (CS: 24) | Weak |
| RSI_14 | 44.4 | Neutral |
| MACD Histogram | 0.01 | Bullish |
| vs SMA20 | 0.988x | Below |
| vs SMA50 | 0.985x | Below |
| vs SMA200 | 0.961x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $333.11
- **Stop Loss:** $320.09 (3.9% risk)
- **Target:** $346.13 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 38
- **Position Value:** $12,658.18
- **Portfolio %:** 12.66%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with balanced risk appetite. VIX near 15th percentile of 52-week range signals calm conditions, while modest yield curve steepening (54bps 10Y-3M) suggests healthy growth expectations. Breadth at 52% indicates selective participation rather than broad-based momentum.*

### Earnings

**Next:** 2026-02-03 (Est: $2.16)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.44 | $3.59 | +4.4% |
| 2025Q2 | $3.81 | $3.38 | -11.2% |
| 2025Q1 | $2.16 | $2.25 | +4.1% |
| 2024Q4 | $2.06 | $2.09 | +1.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*